Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: A randomized, double-blind, placebo-controlled, phase III study

Journal of the American Academy of Dermatology

Volumn 63, Issue 2, 2010, Pages 252-258

  Eun, Hee Chul ^a   Kwon, Oh Sang ^a   Yeon, Je Ho ^a   Shin, Hyo Seung ^a   Kim, Byung Yoon ^a   Ro, Byung In ^b   Cho, Han Kyong ^b   Sim, Woo Young ^c   Lew, Bark Lynn ^c   Lee, Won Soo ^d   Park, Hwa Young ^d   Hong, Seung Phil ^d   Ji, Jae Hong ^d  

^a Seoul National University Hospital   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Kyung Hee University   (South Korea)

^d Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

androgenetic alopecia; dutasteride; male pattern hair loss; treatment

Indexed keywords

DUTASTERIDE; PLACEBO; AZASTEROID; ENZYME INHIBITOR;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EJACULATION DISORDER; ERECTILE DYSFUNCTION; HAIR; HAIR COLOR; HAIR GROWTH; HAIR LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; MALE PATTER HAIR LOSS; MALE TYPE ALOPECIA; MULTICENTER STUDY; PHOTOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; SELF EVALUATION; SEXUAL DYSFUNCTION; SINGLE DRUG DOSE; THYROID CANCER; TREATMENT DURATION; TREATMENT OUTCOME; ADOLESCENT; ALOPECIA; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; MIDDLE AGED; PATIENT SATISFACTION; PHASE 3 CLINICAL TRIAL;

ADOLESCENT; ADULT; ALOPECIA; AZASTEROIDS; ENZYME INHIBITORS; HAIR; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PHOTOGRAPHY; PLACEBOS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955292679     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2009.09.018     Document Type: Article

References (22)

1. O.T. Norwood Male pattern baldness: classification and incidence South Med J 68 1975 1359 1365
2. J.B. Hamilton Patterned loss of hair in man; types and incidence Ann N Y Acad Sci 53 1951 708 728
3. T.F. Cash The psychological effects of androgenetic alopecia in men J Am Acad Dermatol 26 1992 926 931
4. E.A. Olsen Androgenetic alopecia E.A. Olsen, editor. Disorders of hair growth: diagnosis and treatment 1994 McGraw-Hill New York 257 283
5. J. Imperato-McGinley, L. Guerrero, T. Gautier, and R.E. Peterson Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism Science 186 1974 1213 1215
6. E.P. Jenkins, S. Andersson, J. Imperato-McGinley, J.D. Wilson, and D.W. Russell Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase J Clin Invest 89 1992 293 300
7. D.W. Russell, and J.D. Wilson Steroid 5 alpha-reductase: two genes/two enzymes Annu Rev Biochem 63 1994 25 61
8. A.E. Thigpen, R.I. Silver, J.M. Guileyardo, M.L. Casey, J.D. McConnell, and D.W. Russell Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression J Clin Invest 92 1993 903 910
9. H.N. Bramson, D. Hermann, K.W. Batchelor, F.W. Lee, M.K. James, and S.V. Frye Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR J Pharmacol Exp Ther 282 1997 1496 1502
10. F. Debruyne, J. Barkin, P. van Erps, M. Reis, T.L. Tammela, and C. Roehrborn et al. Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia Eur Urol 46 2004 488 494
11. C.G. Roehrborn, L.S. Marks, T. Fenter, S. Freedman, J. Tuttle, and M. Gittleman Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia Urology 63 2004 709 715 (Pubitemid 38479415)
12. E.A. Olsen, M. Hordinsky, D. Whiting, D. Stough, S. Hobbs, and M.L. Ellis et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride J Am Acad Dermatol 55 2006 1014 1023
13. V.H. Price Treatment of hair loss N Engl J Med 341 1999 964 973
14. E.A. Olsen, A.G. Messenger, J. Shapiro, W.F. Bergfeld, M.K. Hordinsky, and J.L. Roberts et al. Evaluation and treatment of male and female pattern hair loss J Am Acad Dermatol 52 2005 301 311
15. K.D. Kaufman, E.A. Olsen, D. Whiting, R. Savin, R. DeVillez, and W. Bergfeld et al. Finasteride in the treatment of men with androgenetic alopecia J Am Acad Dermatol 39 1998 578 589
16. D. Stough Dutasteride improves male pattern hair loss in a randomized study in identical twins J Cosmet Dermatol 6 2007 9 13 (Pubitemid 46390323)
17. M. Olszewska, and L. Rudnicka Effective treatment of female androgenic alopecia with dutasteride J Drugs Dermatol 4 2005 637 640
18. D. Canfield Photographic documentation of hair growth in androgenetic alopecia Dermatol Clin 41 1996 713 721
19. V.A. Randall, and F.J. Ebling Seasonal changes in human hair growth Br J Dermatol 124 1991 146 151
20. M. Courtois, G. Loussouarn, S. Hourseau, and J.F. Grollier Periodicity in the growth and shedding of hair Br J Dermatol 134 1996 47 54 (Pubitemid 26029663)
21. R.V. Clark, D.J. Hermann, G.R. Cunningham, T.H. Wilson, B.B. Morrill, and S. Hobbs Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor J Clin Endocrinol Metab 89 2004 2179 2184
22. A.L. Dallob, N.S. Sadick, W. Unger, S. Lipert, L.A. Geissler, and S.L. Gregoire et al. The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness J Clin Endocrinol Metab 79 1994 703 706